Africa & Middle East

China and South Korea will displace the West as the world’s innovation leaders by 2029

New report claims status of US, EU and UK as leading innovators under threat as they struggle to maximise return on R&D investment. 

China and South Korea will displace the West as the world’s innovation leaders by 2029
15 Jun 2018

South Africa moves to substantive examination for pharma patents, amid fears system could grind to halt

New IP policy looks to get tough on evergreening in pharma industry but also brings country closer to international best practices. 

6 May 2018

Israel's innovation story is extraordinary, but just assuming it will continue would be a big mistake

Series of unique factors contributed to country's status as start-up hub but there are growing signs that more needs to be done to preserve it. 

Latest

View all
7 Jul 2018

All the big legal, market and deals news from the life sciences sector in June

In June’s round-up of life sciences-related news, we report on the US Supreme Court’s decision to grant certiorari in the Helsinn Healthcare v Teva Pharmaceuticals Section 102 dispute, but not in the Cleveland Clinic’s Section 101 case against True… Read more

26 Apr 2018

Israeli startup litigating with Apple inks camera tech licence with Oppo

Corephotonics, a developer of dual camera technologies based in Tel Aviv, last week announced a licensing agreement with Chinese smartphone maker Oppo. It appears to be the first publicly announced IP licence with a major smartphone OEM for the… Read more

14 Nov 2017

In what looks to be a PTAB first, Saudi Arabia's national oil company seeks IPR aimed at Korean rival

The world’s largest oil and gas company Saudi Aramco has filed an inter partes review (IPR) against a Korean petrochemical business in what is a highly unusual move by one of the energy majors. The Saudi national oil giant, which produces 12.5… Read more

Refine content by:

Law & Policy

View all
8 Mar 2016

Major sanctions on ZTE may mean tough times ahead for US-Chinese tech collaboration

The US Department of Commerce has reportedly slapped tough restrictions on telecoms giant ZTE, in a move that could end many of its supplier relationships with US tech companies. Effective today, any company that wants to ship US-made hardware to… Read more

28 Sep 2015

Novartis is the latest Big Pharma player to extend olive branch in Third World patent rights row

While the global quarrel over the pricing of patented drugs continues unabated, Swiss pharmaceutical giant Novartis has announced that it will offer a number of its medicines at significant discount to developing countries. According to a press… Read more

Litigation

View all
28 Sep 2015

Novartis is the latest Big Pharma player to extend olive branch in Third World patent rights row

While the global quarrel over the pricing of patented drugs continues unabated, Swiss pharmaceutical giant Novartis has announced that it will offer a number of its medicines at significant discount to developing countries. According to a press… Read more

Strategy

View all
8 Mar 2016

Major sanctions on ZTE may mean tough times ahead for US-Chinese tech collaboration

The US Department of Commerce has reportedly slapped tough restrictions on telecoms giant ZTE, in a move that could end many of its supplier relationships with US tech companies. Effective today, any company that wants to ship US-made hardware to… Read more

28 Sep 2015

Novartis is the latest Big Pharma player to extend olive branch in Third World patent rights row

While the global quarrel over the pricing of patented drugs continues unabated, Swiss pharmaceutical giant Novartis has announced that it will offer a number of its medicines at significant discount to developing countries. According to a press… Read more

Technology licensing

View all
28 Sep 2015

Novartis is the latest Big Pharma player to extend olive branch in Third World patent rights row

While the global quarrel over the pricing of patented drugs continues unabated, Swiss pharmaceutical giant Novartis has announced that it will offer a number of its medicines at significant discount to developing countries. According to a press… Read more

Find an expert